GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1885.273
- +69.057+3.80%
Notable Analyst Calls This Week: Disney, Super Micro and Amgen Among Top Picks
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
23andMe Shuts Down Therapeutics Discovery Unit, Launching GLP-1 Telehealth Offering
Wall Street Today | Flat Market To Finish Wild Week
S&P 500 Erases Weekly Losses, Nasdaq 100 Ends 4-Week Slide As Bulls Regain Momentum: Friday's Stock Movers At The Close
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Structure Therapeutics Analyst Ratings
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
Moovin Stonks | Friday Market Calm Before Storm After Turbulent Week
74 S&P 500 Stocks That Can Beat the Cash Yield - BofA
Analyzing Eli Lilly In Comparison To Competitors In Pharmaceuticals Industry
S&P 500's Biggest Single-day Gain Proved Buying the Dip Was a Sound Strategy - GS's FICC and Equities
Eli Lilly Unusual Options Activity
Dividend Roundup: Prudential Financial, Progressive, Alcoa, Eli Lilly, and More
Eli Lilly Analyst Ratings
Structure Therapeutics Reports Q2 Results
S&P 500 Records Best Session Since January 2023: Investor Sentiment Improves, But Greed Index Remains In 'Extreme Fear' Zone
S&P rises over 2%, the best in nearly two years, with chip stocks up about 7%, Nasdaq and Chinese stocks up 2.8%, and US Treasury yields and the yen falling for three consecutive days.
The latest employment data alleviates concerns over the US economy, and US stocks rose more than 1.7%. Nvidia's stock rose more than 6%, and Tesla, Alibaba, PDD Holdings, and Tencent ADR rose more than 3%. Bullish on weight loss drug reports, Eli Lilly and Co's stock rose more than 13%, and Novo-Nordisk A/S's US stock rose nearly 8%. The 10-year US Treasury yield rose above 4%, and short-term bond yields rose by 10 basis points. Oil prices rose for the third consecutive day, gold halted its five-day decline, and digital currency had a big increase.
Pyxis Oncology Draws Buy at Stifel on Lead Asset